|
September/October 2008
Volume 2 #3
HIFU or HYPE-U? Assessing innovations
New therapy for advanced PCa to be tested
Male depression and prostate cancer
The WWPCC in Geneva
CPCN respects your right to privacy and will not share information about you. You may unsubscribe from Network News at any time.
• Create and serve community prostate cancer support groups
• Increase public awareness of the disease
• Provide a strong national voice in matters relating to prostate cancer
• how to donate
• subscribe
• contact the editor
• visit the cpcn website
|
|
 |
|
HIFU OR HYPE-U? ASSESSING INNOVATIONS
According to Dr. Larry Goldenberg, HIFU, or high-intensity focused ultrasound, is a "technology with exciting potential," but, up to now, "there has been a lot of hype and marketing that may be clouding the true potential of HIFU." Discover various difficulties inherent in assessing medical advances, and examine the pressures doctors and men face when deciding about new prostate cancer therapies.
|
|
 |
|
|
 |
|
NEW THERAPY FOR ADVANCED PCa TO BE TESTED IN AUSTRALIA
A new and promising approach to treating advanced prostate cancer will soon be tested on patients in Australia, reported Dr. Wayne Tilley at this year's 4th Pacrim Breast and Prostate Cancer Meeting in Whistler, BC. The treatment combines low doses of bicalutamide (Casodex®) with either 17-AAG or vorinostat.
|
|
|
|
|
 |
|
MALE DEPRESSION UNDER-DIAGNOSED: WHY YOU SHOULD CARE
Why should men with prostate cancer care about the possibility that male depression is under-diagnosed? This under-diagnosis probably means there are prostate cancer patients struggling to cope not only with their disease but also with depression. The work of John Oliffe and Melanie Phillips sheds light on this sometimes obscure issue. |
|
|
|
|
 |
|
THE WWPCC AT THE UICC IN GENEVA
In September 2008, CPCN's Bob Shiell and Wally Seeley helped present the mission and accomplishments of the Worldwide Prostate Cancer Coalition (WWPCC) to the prestigious UICC World Cancer Congress in Geneva. It was an historic moment in the relationship between health care professionals and prostate cancer survivors.
|
|
|
|
|
|
|
